Harvard Bioscience, Inc. (HBIO)
8.46
-0.10
(-1.17%)
USD |
NASDAQ |
Oct 07, 16:00
8.46
0.00 (0.00%)
After-Hours: 20:00
Harvard Bioscience Enterprise Value : 76.67M for Oct. 6, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 76.67M |
| October 05, 2026 | 76.40M |
| October 02, 2026 | 75.67M |
| October 01, 2026 | 74.71M |
| September 30, 2026 | 73.76M |
| September 29, 2026 | 73.94M |
| September 28, 2026 | 74.03M |
| September 25, 2026 | 73.94M |
| September 24, 2026 | 74.21M |
| September 23, 2026 | 74.35M |
| September 22, 2026 | 73.76M |
| September 21, 2026 | 74.12M |
| September 18, 2026 | 73.89M |
| September 17, 2026 | 74.26M |
| September 16, 2026 | 73.98M |
| September 15, 2026 | 74.12M |
| September 14, 2026 | 74.53M |
| September 11, 2026 | 74.26M |
| September 10, 2026 | 74.80M |
| September 09, 2026 | 73.89M |
| September 08, 2026 | 73.89M |
| September 04, 2026 | 74.21M |
| September 03, 2026 | 74.12M |
| September 02, 2026 | 75.03M |
| September 01, 2026 | 74.30M |
| Date | Value |
|---|---|
| August 31, 2026 | 74.62M |
| August 28, 2026 | 73.80M |
| August 27, 2026 | 73.67M |
| August 26, 2026 | 72.53M |
| August 25, 2026 | 72.21M |
| August 24, 2026 | 72.07M |
| August 21, 2026 | 71.75M |
| August 20, 2026 | 72.07M |
| August 19, 2026 | 69.93M |
| August 18, 2026 | 69.43M |
| August 17, 2026 | 67.29M |
| August 14, 2026 | 68.00M |
| August 13, 2026 | 68.07M |
| August 12, 2026 | 65.79M |
| August 11, 2026 | 65.61M |
| August 10, 2026 | 66.79M |
| August 07, 2026 | 67.16M |
| August 06, 2026 | 65.88M |
| August 05, 2026 | 66.70M |
| August 04, 2026 | 66.43M |
| August 03, 2026 | 66.43M |
| July 31, 2026 | 65.47M |
| July 30, 2026 | 65.43M |
| July 29, 2026 | 65.56M |
| July 28, 2026 | 64.65M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Agilent Technologies, Inc. | 49.94B |
| Bio-Rad Laboratories, Inc. | 9.612B |
| Bruker Corp. | 10.87B |
| Danaher Corp. | 175.07B |
| Illumina, Inc. | 42.66B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.91M |
| Revenue (Quarterly) | 22.73M |
| Total Expenses (Quarterly) | 25.64M |
| EPS Diluted (Quarterly) | -0.643 |
| Gross Profit Margin (Quarterly) | 51.96% |
| Profit Margin (Quarterly) | -12.80% |
| Earnings Yield | -27.46% |
| Operating Earnings Yield | 1.51% |
| Normalized Earnings Yield | -25.95 |